Yue X, et al. - The Advisory Committee on Immunization Practices recommends hepatitis A (HepA) and hepatitis B (HepB) vaccination for persons with chronic liver disease (CLD). Herein, researchers assessed self-reported HepA (≥1 and ≥2 doses) and HepB vaccination (≥1 and ≥3 doses) coverage among adults who reported a chronic or long-term liver condition, using data from the 2014 and 2015 National Health Interview Surveys (NHIS). Suboptimal HepA and HepB vaccination, as well as the occurrence of missed opportunities to vaccinate, was reported among adults with CLD. Providers should adhere to recommendations to vaccinate persons with CLD to increase vaccination among this population.